Valeant Pharmaceuticals – The Perils Of The Debt Acquisition Model
Valeant Pharmaceuticals (VRX) needs a ‘fix it” third party to come in and stop the bleeding. Moreover, the current management team is stuck in ‘deer in headlights mode’, and needs to start taking proactive steps to resolve the overhang that is weighing down investor confidence on the street.
Bloomberg Declared Emerging Markets In Bull Status — Maybe That’s Just Bull
Friday, a Bloomberg TV announcer said emerging markets are now in a Bull phase. Don’t get overly excited by that call. I know why they said that, but question the utility of their definition. Vanguard’s emerging markets ETF (VWO), for example, closed at $34.40, up 11.2% from its multi-year closing low of $30.74; and up […]
E Cameron International Is In For A World Of Hurt
I have been following Cameron International (CAM) since Q4 2014 when the divergence in oil prices looked like it was here to stay. However, I got greedy and forgot to take profits on my short play. I am still chafing from losses I incurred after Schlumberger’s (SLB) ill-fated takeover announcement in August. Cameron has since […]
CanopyBoulder Raises More Than $2 Million For Cannabis Startups
On March 18, 2016, CanopyBoulder announced that it had raised a $2 million fund to invest in two classes of startups for its business accelerator program in 2016. CanopyBoulder’s third class of 10 companies started its 16-week program on Feb. 29, including companies focusing on everything from a monthly subscription box to a home-grow system and an independent testing […]
The Breadth Of Shortage
The yield on the Japanese government’s 10-year paper traded negative yesterday for the 17th straight session. When Haruhiko Kuroda first announced his negative rate experimentation, the 10-year JGB was low but still safely positive, yielding 22.9 bps on January 28. It would be negative for the first time on February 9 right as the rest […]
S&P 500 Snapshot: Finally Up For The Year
Our benchmark S&P 500 continued the post-FOMC rally with a modest morning rally to its 0.58% intraday high in the late morning. It trended sideways through the lunch hour, slumped a bit and then rose early in the final hour to a narrow range prior to its 0.44% closing gain. Today was the 53rd market […]
March 11, 2016: ECRI’s WLI Growth Index Improves But Still Negative
ECRI’s WLI Growth Index which forecasts economic growth six months forward – continued in negative territory. This index now spent 32 consecutive weeks in negative territory. ECRI also released their coincident and lagging indices this week and are shown below. Current ECRI WLI Level and Growth Index: Here is this week’s update on ECRI’s Weekly […]
Mother Russia!
While most are watching U.S. equities rip higher, we’re continuing to see strength from emerging markets. Previously, we highlighted the breakout taking place in Brazil. Up 13% since we released that research, Brazil hasn’t disappointed. Though nothing is guaranteed, and price knows more than we do, we are seeing a similar development out of Russia. Using […]
Dividend ETF Hits New 52-Week High
For investors seeking momentum, ProShares S&P 500 Aristocrats ETF (NOBL – ETF report) is probably on their radar now. The fund just hit a 52-week high, and is up about 41% from its 52-week low price of $36.98/share. But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook […]
Precious Metals Ignore Correction Calls
Gold and gold stocks have refused to correct for more than a few days at a time. Weakness is being bought and quickly. Gold has gained over $200/oz but not corrected by more than 6%. The miners (GDX) have endured three roughly 10% corrections in the past six weeks but nothing greater. A few weeks […]
